Clinical Trial Update: Neoadyuvant High-dose of Ifosfamide and Concurrent Radiotherapy in Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating neoadjuvant high-dose ifosfamide with concurrent radiotherapy in soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: COMPLETED